Bharat Biotech Current Affairs, GK & News

India’s first intra-nasal Corona vaccine: GK & Current Affairs Facts

September 8, 2022

The country’s first intranasal COVID vaccine iNCOVACC by Bharat Biotech has recently received DCGI approval for primary immunization against the infection for people above the age of 18 years. This vaccine has been named ChAd36-SARS-CoV-S COVID-19. Highlights ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) Recombinant Nasal Vaccine for COVID-19 by Bharat Biotech is the first of its ..

Month: 

Category: 

Topics:  • • • • • • • • • • • •

Bharat Biotech’s intranasal vaccine – Update

August 16, 2022

Bharat Biotech recently sought approval for its intranasal Covid vaccine candidate, BBV154, as two-dose vaccine as well as booster dose. It submitted data from Phase 3 clinical trials of BBV154 to seek approval. Highlights: The heterologous booster infers that, third or subsequent dose of the vaccine is not similar to its primary dose. Usually, primary doses include two ..

Month: 

Category: 

Topics:  • • • • • •

EUA to Corbevax for 12-18 Age Group

February 22, 2022

A vaccine manufacturer based in Hyderabad, Biological E has received emergency use authorization (EUA) from the drug regulator of India for its Covid-19 vaccine for children aged 12 to 18. Overview: Biological E’s Corbevax vaccine was earlier approved by the Drugs Controller General of India for limited usage in adults during emergency situations in 2019. ..

Month: 

Category: 

Topics:  • • • •

Bharat Biotech Nasal Booster Trials

January 31, 2022

The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are being introduced for the vulnerable population. The booster doses will provide the strength to fight against the third wave that is violently spreading the Omicron. About the ..

Month: 

Category:  •

Topics:  • • • • • • • •

Conditional market approval for Covaxin, Covishield

January 29, 2022

The Drug regulator in India has granted conditional market approval for the COVISHIELD and COVAXIN vaccines. This means that the private hospitals shall administer the vaccines. However, the vaccines will not be available in retail medical stores. What is conditional market authorisation? The Serum Institute vaccine COVISHELD and Bharat Biotech’s COVAXIN were administered in the ..

Month: 

Category: 

Topics:  • • • • • • • • • • • •

Padma Awards 2022

January 27, 2022

The Padma Awards 2022 is to be conferred to vaccine makers to semiconductor market rulers. This time, the Padma awards are being presented to a diversified list of recipients. Around 128 people are to receive the award in 2022. The awards will be presented by President Ram Nath Kovind at Rashtrapati Bhawan. Padma Vibhushan The ..

Month: 

Category: 

Topics:  • • • • • • • • • • • • • • • • • • • • • • • • • • •